DOC Stock Analysis — Healthpeak Properties
Sector: Healthcare REIT
AI Verdict
Healthpeak trades at 85.8x next year's earnings with -20.9% EPS growth expected, so you're paying a premium the numbers don't yet support unless its property moat delivers a surprise turnaround.
Competitive Moat
Healthpeak owns and operates a portfolio of high-barrier medical office and life science properties clustered in top-tier U.S. health markets, making it difficult for new entrants to replicate its tenant relationships and location network. Its scale and deep ties with major healthcare providers create sticky, long-term leases that buffer against tenant churn.
Summary
Healthpeak's sky-high 85.8x forward P/E and -20.9% expected EPS decline make it a standout for valuation risk in healthcare REITs.
Where It Stands
With a 17.34% 1-year return, RSI at 73.1 (overbought), and a forward P/E of 85.8x versus the sector median of 22x, the stock is priced for perfection despite shrinking earnings.
Key Metrics
- RSI: 73.1 — Overbought
- Trailing P/E: 67.9x
- Forward P/E: 85.8x
- Earnings Growth: -0.2%
- Revenue Growth: +0.0%
- Market Cap: $14.9B
- Dividend Yield: 0.06%
- 1-Year Return: 17.34%
- 52-Week High: $22.13
- 52-Week Low: $15.70
Analyst Consensus
11 Buy · 13 Hold · 0 Sell (24 analysts)
Bull Case
The 17.34% 1-year return shows investors have rewarded Healthpeak for its defensive property portfolio and stable rent collection.
Bear Case
A forward P/E of 85.8x while EPS is expected to fall -20.9% means even a modest P/E compression to the sector median of 22x would imply a 74% downside from here.
Catalyst to Watch
Watch for quarterly guidance updates—any sign of stabilizing or rebounding EPS could justify the premium, but further guidance cuts would likely trigger a sharp rerating.